We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0KSX market cap is 11.54B. The company's latest EPS is USD 7.5955 and P/E is 18.00.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.82B | 9.44B | 10.79B | 9.88B | 9.25B |
| Operating Income | 1.23B | 1.97B | 2.38B | 1.43B | 1.26B |
| Net Income | 858M | 1.43B | 2B | 946M | 854M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.84B | 14.03B | 13.61B | 12.84B | 14.02B |
| Total Liabilities | 7.08B | 7.14B | 7.05B | 6.83B | 7.6B |
| Total Equity | 5.69B | 6.81B | 6.48B | 5.93B | 6.34B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.24B | 2.01B | 2.23B | 1.72B | 1.27B |
| Investing | -411M | -772M | 21M | -543M | -1.06B |
| Financing | 225M | -1.27B | -2.54B | -1.73B | 160M |
| Market Cap | 11.54B |
| Price to Earnings Ratio | 18.00 |
| Price to Sales Ratio | 1.66 |
| Price to Cash Ratio | 22.41 |
| Price to Book Ratio | 2.39 |
| Dividend Yield | - |
| Shares Outstanding | 112.44M |
| Average Volume (1 week) | 36.34k |
| Average Volume (1 Month) | 11.15k |
| 52 Week Change | 0.00% |
| 52 Week High | 102.60 |
| 52 Week Low | 102.60 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Quest Diagnostics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.questdiagnostics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
